LYDALO Trademark

Trademark Overview

On Friday, August 29, 2008, a trademark application was filed for LYDALO with the United States Patent and Trademark Office. The USPTO has given the LYDALO trademark a serial number of 77559257. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 16, 2009. This trademark is owned by KOWA COMPANY, LTD.. The LYDALO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, the peripheral nervous system, the sensory organs, the circulatory system, the respiratory system, and the digestive system; pharmaceutical preparations comprising hormones; pharmaceutical preparations for the treatment of urogenital or anal conditions; pharmaceutical preparations for the treatment of dermatological conditions; pharmaceutical preparations comprising vitamins and amino acids; pharmaceutical preparations for the treatment of blood conditions and metabolic conditions; pharmaceutical preparations for treating tumors and lesions; pharmaceutical preparations comprising antibiotics; pharmaceutical preparations for treating medical conditions caused by parasites; pharmaceutical preparations comprising labeled isotopes; and pharmaceutical preparations comprising narcotics
lydalo

General Information

Serial Number77559257
Word MarkLYDALO
Filing DateFriday, August 29, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 16, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 20, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, the peripheral nervous system, the sensory organs, the circulatory system, the respiratory system, and the digestive system; pharmaceutical preparations comprising hormones; pharmaceutical preparations for the treatment of urogenital or anal conditions; pharmaceutical preparations for the treatment of dermatological conditions; pharmaceutical preparations comprising vitamins and amino acids; pharmaceutical preparations for the treatment of blood conditions and metabolic conditions; pharmaceutical preparations for treating tumors and lesions; pharmaceutical preparations comprising antibiotics; pharmaceutical preparations for treating medical conditions caused by parasites; pharmaceutical preparations comprising labeled isotopes; and pharmaceutical preparations comprising narcotics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 3, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKOWA COMPANY, LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNagoya
JP
Party NameKOWA COMPANY, LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNagoya
JP

Trademark Events

Event DateEvent Description
Monday, November 16, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 16, 2009ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 14, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 20, 2009PUBLISHED FOR OPPOSITION
Wednesday, December 31, 2008NOTICE OF PUBLICATION
Wednesday, December 17, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 17, 2008ASSIGNED TO LIE
Tuesday, December 9, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 5, 2008ASSIGNED TO EXAMINER
Wednesday, September 3, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

lydalo pharmaceutical preparations conditions system comprising treatment treating nervous tumors metabolic